BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22098831)

  • 1. Standard D2 and modified nodal dissection for gastric adenocarcinoma.
    Hoshi H
    Surg Oncol Clin N Am; 2012 Jan; 21(1):57-70. PubMed ID: 22098831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D2 lymph node dissection improves staging in patients with gastric adenocarcinoma.
    Putchakayala K; Difronzo LA
    Am Surg; 2011 Oct; 77(10):1326-9. PubMed ID: 22127080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.
    Volpe CM; Koo J; Miloro SM; Driscoll DL; Nava HR; Douglass HO
    J Am Coll Surg; 1995 Jul; 181(1):56-64. PubMed ID: 7599772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase-II clinical trial of laparoscopy-assisted distal gastrectomy with D2 lymph node dissection for gastric cancer patients.
    Lee JH; Kim YW; Ryu KW; Lee JR; Kim CG; Choi IJ; Kook MC; Nam BH; Bae JM
    Ann Surg Oncol; 2007 Nov; 14(11):3148-53. PubMed ID: 17705092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative study of D1 and D2 ganglionic dissection in advanced gastric cancer at Rebagliati Hospital].
    Cornejo C; Portanova M
    Rev Gastroenterol Peru; 2006; 26(4):351-6. PubMed ID: 17211484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resection for gastric cancer in the community.
    van de Velde CJ
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S90-3. PubMed ID: 16399441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Learning curve for total gastrectomy with D2 lymph node dissection: cumulative sum analysis for qualified surgery.
    Lee JH; Ryu KW; Lee JH; Park SR; Kim CG; Kook MC; Nam BH; Kim YW; Bae JM
    Ann Surg Oncol; 2006 Sep; 13(9):1175-81. PubMed ID: 16947008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastasis in para-aortic lymph nodes in patients with advanced gastric cancer, treated with extended lymphadenectomy.
    Yonemura Y; Wu CC; Fukushima N; Honda I; Bandou E; Kawamura T; Kamata S; Yamamoto H; Kim BS; Matsuki N; Sawa T; Noh SH;
    Hepatogastroenterology; 2007 Mar; 54(74):634-8. PubMed ID: 17523339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastric cancer: D2 dissection or low Maruyama Index-based surgery--a debate.
    Douglass HO; Hundahl SA; Macdonald JS; Khatri VP
    Surg Oncol Clin N Am; 2007 Jan; 16(1):133-55. PubMed ID: 17336241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does D2 plus para-aortic nodal dissection surgery offer a better survival outcome compared to D2 surgery only for gastric cancer consistently? A definite result based on a hospital population of nearly two decades.
    Zhang Y; Tian S
    Scand J Surg; 2013; 102(4):251-7. PubMed ID: 24056132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. D1 versus D2 lymphadenectomy and volume versus training: ongoing debate in gastric cancer surgery.
    Mack LA
    J Surg Oncol; 2006 Apr; 93(5):345-6. PubMed ID: 16550554
    [No Abstract]   [Full Text] [Related]  

  • 12. Outcomes of adjuvant chemoradiotherapy after a radical gastrectomy and a D2 node dissection for gastric adenocarcinoma.
    Leong CN; Chung HT; Lee KM; Shakespeare TP; Mukherjee RK; Wong LC; Lu JJ; Tey J; Lim R; So JB; Back MF
    Cancer J; 2008; 14(4):269-75. PubMed ID: 18677137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of station-specific lymph node yield in laparoscopic and open distal gastrectomy for early gastric cancer.
    Bouras G; Lee SW; Nomura E; Tokuhara T; Tsunemi S; Tanigawa N
    Surg Laparosc Endosc Percutan Tech; 2011 Dec; 21(6):424-8. PubMed ID: 22146165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes and survival after laparoscopic gastrectomy for adenocarcinoma. Analysis on 65 patients operated on by conventional or robot-assisted minimal access procedures.
    Pugliese R; Maggioni D; Sansonna F; Ferrari GC; Forgione A; Costanzi A; Magistro C; Pauna J; Di Lernia S; Citterio D; Brambilla C
    Eur J Surg Oncol; 2009 Mar; 35(3):281-8. PubMed ID: 18342480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved survival after resectable non-cardia gastric cancer in The Netherlands: the importance of surgical training and quality control.
    Krijnen P; den Dulk M; Meershoek-Klein Kranenbarg E; Jansen-Landheer ML; van de Velde CJ
    Eur J Surg Oncol; 2009 Jul; 35(7):715-20. PubMed ID: 19144490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of stage migration on the comparison of surgical outcomes between D2 gastrectomy and D3 gastrectomy (para-aortic lymph node dissection): a multi-institutional retrospective study.
    Kunisaki C; Takahashi M; Fukushima T; Nagahori Y; Akiyama H; Makino H; Otsuka Y; Ono HA; Kosaka T; Takagawa R; Shimada H
    Am J Surg; 2008 Sep; 196(3):358-63. PubMed ID: 18466868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status and future perspectives in gastric cancer management.
    Roukos DH
    Cancer Treat Rev; 2000 Aug; 26(4):243-55. PubMed ID: 10913380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrectomy with D2 lymph node dissection in gastric cancer: a retrospective study at a single institution.
    Kasakura Y; Fujii M; Mochizuki F; Asaki H; Kobayashi M
    Int Surg; 2001; 86(1):50-6. PubMed ID: 11890341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastric cancer eastern experience.
    Sasako M
    Surg Oncol Clin N Am; 2012 Jan; 21(1):71-7. PubMed ID: 22098832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional outcomes after extended surgery for gastric cancer.
    Kurokawa Y; Sasako M; Sano T; Shibata T; Ito S; Nashimoto A; Kurita A; Kinoshita T;
    Br J Surg; 2011 Feb; 98(2):239-45. PubMed ID: 21104822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.